Clinical Study Of Xiaju Huayu Capsule In Phase Ⅱ Cardiac Rehabilitation After Percutaneous Coronary Intervention For Coronary Heart Disease

Objective To observe the clinical efficacy of Xiaju Hua Yu Capsule combined with cardiac rehabilitation(phase Ⅱ)on locomotor function,quality of life and Traditional Chinese Medicine(TMC)syndromes of patients with coronary heart disease after PCI.Methods Sixty patients eligible were divided into experimental group(n=30)and control group(n=30)using random number table method.Control group was given guidance to improve lifestyle,evidence-based medication for secondary prevention of coronary heart disease and weekly regular aerobic exercise combined with resistance exercise.On the basis of intervention in the control group,patients in the experimental group were given Xiaju Huayu capsule 2g three times a day.The patients of the 2 groups was intervented 8 weeks.After the intervention,efficacy indicators were collected,such as score of China questionnaire of quality of life inpatients with cardiobascular disease(CQQC),6 minutes walking distance(6MWD),maximum oxygen uptake(VO2max),anaerobic threshold(AT)and TCM syndrome score.Statistical software SPSS 17.0 was used for statistical analysis of the above data.Results After the intervention,the scores of CQQC、6MWD、VO2max and AT were higher than treatment before in the two groups.And the TCM syndrome scores were lower than before treatment.Beside of the medical condition in CQQC,other indexes in the treatment group were better than the control group,and there was significant differences between the two groups(P<0.05).Conclusion Xiaju Huayu capsule combined with cardiac rehabilitation can effectually improve coronary heart disease patients’ locomotor function,quality of life and TCM syndrome who was sufferd PCI.Xiaju Huayu capsule was secure and no obvious untoward reactions have been detected.